Clinical Updates | Conference Update Resource List

Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsA network building capacity to prevent, manage and treat hepatitis B and C in NYC

Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsAn Academy Award winning director is seeking Hep C patients for a web documentary film about Hep C and the challenges related to living with the disease.
DAKLINZA is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the need for co-administration of interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection.
New York state’s Medicaid program spent $193.2 million during the first six months of 2014 on Sovaldi, the controversial Hepatitis C drug that carries an $84,000-per-patient price tag.
HHS has released a Request for Information, asking organizations to detail viral hepatitis initiatives they implemented in 2014 and 2015.
The FDA has approved the drug Epclusa to treat adult patients with chronic Hep C both with and without cirrhosis.
The majority of New Yorkers with chronic hepatitis C remain undiagnosed. The Centers for Disease Control (CDC) now recommend a one-time testing of all Baby Boomers for hepatitis C. New York City is the epicenter of the hepatitis C epidemic, with nearly 200,000 residents chronical...
The U.S. Preventive Services Task Force posted for public comment its draft recommendation statement on screening and behavioral counseling interventions in primary care to reduce alcohol misuse.
Patient Health Perspectives is looking for people who have been diagnosed with hepatitis C who are interested in sharing their story in a video which will be used to educate others about the HCV patient experience.
